Hellenic Cooperative Oncology Group
hecog.grLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
54
Active
4
Phase 3
0
Total enrollment
23,435
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Breast Cancer10
- Non Small Cell Lung Cancer5
- Metastatic Breast Cancer3
- Ovarian Cancer3
- Colorectal Cancer2
- Prostate Cancer2
- Lung Cancer Non-small Cell Stage IV1
- Prostate Cancer Metastatic1
Frequently asked questions about Hellenic Cooperative Oncology Group
- How many clinical trials does Hellenic Cooperative Oncology Group have on ClinicalTrials.gov?
- Hellenic Cooperative Oncology Group is listed as the lead sponsor on 54 clinical trials in ClinicalTrials.gov, 4 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Hellenic Cooperative Oncology Group's trials are in Phase 3?
- 0 of Hellenic Cooperative Oncology Group's trials are in Phase 3.
- What therapeutic areas does Hellenic Cooperative Oncology Group focus on?
- Hellenic Cooperative Oncology Group's most-studied conditions on ClinicalTrials.gov are Breast Cancer, Non Small Cell Lung Cancer, Metastatic Breast Cancer, Ovarian Cancer, Colorectal Cancer.